Design Therapeutics (DSGN) 2025 Conference September 04, 2025 10:55 AM ET Speaker0All right, we're ready to get started. Welcome everyone. I'm Josh Schimmer from the Cantor Biotech Equity Research Team and pleased to introduce from Design Therapeutics, have Prateek Shah, Chief Executive Officer. We're going back to some GeneTACs. So, Prateek, thanks so much for joining.Why don't you frame Design Therapeutics and give us a quick overview of how the GeneTAC platform works?Speaker1What makes design unique and ...